OP 7.2 - 00035 Impact of 10-1074LS and 3BNC117-LS on viral rebound dynamics following treatment interruption six months after dosing: four cases from the open label arm of the RIO trial - M. Lee; S. Collins; S. Kinloch; J. Fox; K. Seaton; G. Tomaras; M. Caskey; M. Nussenzweig; J. Frater; S. Fidle (Elsevier, 2022)